The 8 analysts offering 12-month price forecasts for Chinook Therapeutics Inc have a median target of 31.50, with a high estimate of 48.00 and a low estimate of 28.00. The median estimate represents a +75.00% increase from the last price of 18.00.
The current consensus among 9 polled investment analysts is to Buy stock in Chinook Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.62
Reporting Date Aug 11
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.